Ten years of liver transplantation - An evolving understanding of late graft loss

被引:110
作者
Abbasoglu, O [1 ]
Levy, MF [1 ]
Brkic, BB [1 ]
Testa, G [1 ]
Jeyarajah, DR [1 ]
Goldstein, RM [1 ]
Husberg, BS [1 ]
Gonwa, TA [1 ]
Klintmalm, GB [1 ]
机构
[1] Baylor Univ, Med Ctr, Transplantat Serv, Dallas, TX 75246 USA
关键词
D O I
10.1097/00007890-199712270-00030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We undertook this study to understand the causes of late graft loss and long-term outcome in orthotopic liver transplantation (OLT) recipients, Methods. Prospectively collected data of 1174 consecutive OLT in 1045 adult patients who received liver grafts between April 1985 and August 1995 were reviewed. The causes of graft loss, pretransplant patient characteristics, and posttransplant events were analyzed in patients who survived at least 1 year after OLT, in an attempt to establish a link between these factors and graft loss, Results. One hundred fifty-nine (17.9%) grafts were lost after the first year. Of these, 132 grafts were lost by death and 27 by retransplantation. Recipients who survived the first year (n=884) had 5- and 10-year survivals of 81.4% and 67.2%, respectively, Death with a functioning graft occurred in 97 (61%) patients. The main causes of late graft loss were recurrent disease (n=48), cardiovascular and cerebral vascular accidents (n=28), infections (n=24), and chronic rejection (n=15). Pretransplant heart disease and diabetes were found to be significant risk factors for late graft loss due to cardiovascular diseases and cerebral vascular accidents, Conclusions. Survival of OLT patients who live beyond the first posttransplant year is excellent. Some patient characteristics may be associated with late graft loss, Compared with previous reports, this study shows an increased incidence of late graft loss secondary to recurrent diseases, de novo malignancies, cardiovascular diseases, and cerebral vascular accidents. Chronic rejection seems to be a less frequent cause of late graft loss, The prevention of recurrent disease and better immunosuppression may further improve these results.
引用
收藏
页码:1801 / 1807
页数:7
相关论文
共 45 条
  • [1] Hepatic artery stenosis after liver transplantation - Incidence, presentation, treatment, and long term outcome
    Abbasoglu, O
    Levy, MF
    Vodapally, MS
    Goldstein, RM
    Husberg, BS
    Gonwa, TA
    Klintmalm, GB
    [J]. TRANSPLANTATION, 1997, 63 (02) : 250 - 255
  • [2] Abbasoglu O, 1995, NEW DEV TRANSPLANT M, V2, P9
  • [3] An analysis of late deaths after liver transplantation
    Asfar, S
    Metrakos, P
    Fryer, J
    Verran, D
    Ghent, C
    Grant, D
    Bloch, M
    Burns, P
    Wall, W
    [J]. TRANSPLANTATION, 1996, 61 (09) : 1377 - 1381
  • [4] BACKMAN L, 1993, TRANSPLANTATION, V55, P1078
  • [5] 1,000 LIVER-TRANSPLANTS - THE LESSONS LEARNED
    BUSUTTIL, RW
    SHAKED, A
    MILLIS, JM
    JURIM, O
    COLQUHOUN, SD
    SHACKLETON, CR
    NUESSE, BJ
    CSETE, M
    GOLDSTEIN, LI
    MCDIARMID, SV
    [J]. ANNALS OF SURGERY, 1994, 219 (05) : 490 - 499
  • [6] Long-term outcome of hepatitis C infection after liver transplantation
    Cane, EJ
    Portmann, BC
    Naoumov, NV
    Smith, HM
    Underhill, JA
    Donaldson, PT
    Maertens, G
    Williams, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) : 815 - 820
  • [7] COLONNA JO, 1992, ANN SURG, V216, P344
  • [8] DEE GW, 1995, CLIN TRANSPLANT, V9, P463
  • [9] LONG-TERM INFECTIOUS COMPLICATIONS OF LIVER-TRANSPLANTATION
    DOMINGUEZ, EA
    [J]. SEMINARS IN LIVER DISEASE, 1995, 15 (02) : 133 - 138
  • [10] LIVER-TRANSPLANTATION - THE CHALLENGES OF THE 1990S
    DOUSSET, B
    HOUSSIN, D
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1992, 46 (2-3) : 79 - 83